Cargando…

Functionally Recurrent Rearrangements of the MAST Kinase and Notch Gene Families in Breast Cancer

Breast cancer is a heterogeneous disease, exhibiting a wide range of molecular aberrations and clinical outcomes. Here we employed paired-end transcriptome sequencing to explore the landscape of gene fusions in a panel of breast cancer cell lines and tissues. We observed that individual breast cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robinson, Dan R., Kalyana-Sundaram, Shanker, Wu, Yi-Mi, Shankar, Sunita, Cao, Xuhong, Ateeq, Bushra, Asangani, Irfan A., Iyer, Matthew, Maher, Christopher A., Grasso, Catherine S., Lonigro, Robert J., Quist, Michael, Siddiqui, Javed, Mehra, Rohit, Jing, Xiaojun, Giordano, Thomas J., Sabel, Michael S., Kleer, Celina G., Palanisamy, Nallasivam, Natrajan, Rachael, Lambros, Maryou B., Reis-Filho, Jorge S., Kumar-Sinha, Chandan, Chinnaiyan, Arul M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233654/ https://www.ncbi.nlm.nih.gov/pubmed/22101766 http://dx.doi.org/10.1038/nm.2580

Ejemplares similares

Transcriptome Sequencing to Detect Gene Fusions in Cancer
por: Maher, Christopher A., et al.
Publicado: (2009)

Landscape of gene fusions in epithelial cancers: seq and ye shall find
por: Kumar-Sinha, Chandan, et al.
Publicado: (2015)

Gene Fusion Markup Language: a prototype for exchanging gene fusion data
por: Kalyana-Sundaram, Shanker, et al.
Publicado: (2012)

The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer
por: Yu, Jindan, et al.
Publicado: (2010)

The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer
por: Grasso, Catherine S., et al.
Publicado: (2012)

miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancers
por: Hua, Youjia, et al.
Publicado: (2013)

BETting on a new prostate cancer treatment
por: Asangani, Irfan A, et al.
Publicado: (2014)

Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma
por: Asangani, Irfan A., et al.
Publicado: (2012)

HPeak: an HMM-based algorithm for defining read-enriched regions in ChIP-Seq data
por: Qin, Zhaohui S, et al.
Publicado: (2010)

The tumor suppressor gene rap1GAP is silenced by mir-101-mediated EZH2 overexpression in invasive squamous cell carcinoma
por: Banerjee, Rajat, et al.
Publicado: (2011)

Transcriptome Sequencing Identifies PCAT-1, a Novel lincRNA Implicated in Prostate Cancer Progression
por: Prensner, John R., et al.
Publicado: (2011)

The miR-124-Prolyl Hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression
por: Chakravarthi, Balabhadrapatruni V. S. K., et al.
Publicado: (2014)

Molecular profiling of ETS and non‐ETS aberrations in prostate cancer patients from northern India
por: Ateeq, Bushra, et al.
Publicado: (2015)

Heat Shock Protein Beta-1 Modifies Anterior to Posterior Purkinje Cell Vulnerability in a Mouse Model of Niemann-Pick Type C Disease
por: Chung, Chan, et al.
Publicado: (2016)

The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing
por: Cieslik, Marcin, et al.
Publicado: (2015)

Transcriptome Meta-Analysis of Lung Cancer Reveals Recurrent Aberrations in NRG1 and Hippo Pathway Genes
por: Dhanasekaran, Saravana M., et al.
Publicado: (2014)

Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression
por: Goel, Sakshi, et al.
Publicado: (2021)

Evaluation of Tissue PCA3 Expression in Prostate Cancer by RNA in situ Hybridization - A Correlative Study with Urine PCA3 and TMPRSS2-ERG
por: Warrick, Joshua I., et al.
Publicado: (2013)

Determination of HER2 Amplification Status on Tumour DNA by Digital PCR
por: Garcia-Murillas, Isaac, et al.
Publicado: (2013)

Novel Dual Color Immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma
por: Bhalla, Ritu, et al.
Publicado: (2013)

Double-Negative Prostate Cancer Masquerading as a Squamous Cancer of Unknown Primary: A Clinicopathologic and Genomic Sequencing-Based Case Study
por: Cackowski, Frank C., et al.
Publicado: (2020)

Targeting the MLL complex in castration resistant prostate cancer
por: Malik, Rohit, et al.
Publicado: (2015)

Urothelial Cancer With Occult Bone Marrow Metastases and Isolated Thrombocytopenia
por: Alva, Ajjai, et al.
Publicado: (2015)

Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer
por: Goswami, Moloy T., et al.
Publicado: (2015)

A Comparison of Single Molecule and Amplification Based Sequencing of Cancer Transcriptomes
por: Sam, Lee T., et al.
Publicado: (2011)

Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer
por: Tiwari, Ritika, et al.
Publicado: (2020)

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast
por: Natrajan, Rachael, et al.
Publicado: (2014)

RNA-Seq Accurately Identifies Cancer Biomarker Signatures to Distinguish Tissue of Origin()
por: Wei, Iris H., et al.
Publicado: (2014)

Pseudogene Associated Recurrent Gene Fusion in Prostate Cancer()()
por: Chakravarthi, Balabhadrapatruni VSK, et al.
Publicado: (2019)

Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer
por: Dadhania, Vipulkumar, et al.
Publicado: (2022)

On how CCN6 suppresses breast cancer growth and invasion
por: Huang, Wei, et al.
Publicado: (2011)

Genetic characterization of breast cancer and implications for clinical management
por: Geyer, Felipe C, et al.
Publicado: (2009)

The status of epidermal growth factor receptor in borderline ovarian tumours
por: Showeil, Rania, et al.
Publicado: (2016)

A Novel RNA In Situ Hybridization Assay for the Long Noncoding RNA SChLAP1 Predicts Poor Clinical Outcome After Radical Prostatectomy in Clinically Localized Prostate Cancer()()
por: Mehra, Rohit, et al.
Publicado: (2014)

Genomics driven precision oncology in advanced biliary tract cancer improves survival
por: Kumar-Sinha, Chandan, et al.
Publicado: (2023)

Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer
por: Wilkerson, Paul M, et al.
Publicado: (2016)

High Serine-arginine Protein Kinase 1 Expression with PTEN Loss Defines Aggressive Phenotype of Prostate Cancer Associated with Lethal Outcome and Decreased Overall Survival
por: Abou-Ouf, Hatem, et al.
Publicado: (2020)

Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer
por: Parolia, Abhijit, et al.
Publicado: (2019)

Inherent Signals in Sequencing-Based Chromatin-ImmunoPrecipitation Control Libraries
por: Vega, Vinsensius B., et al.
Publicado: (2009)

Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1): a target for cancer therapeutic intervention?
por: Jaiswal, Praveen Kumar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8h5bjio3a7tkfjk0752gd0n0hd